Abstract
Mycoplasma is the smallest self-replicating bacteria, figuring as common contaminant of eukaryotic cell cultures. Production inputs and operator’s manipulation seem to be the main sources of such contamination. Many analytical approaches have been applied for mycoplasma detection in cell cultures and also in biological products. However, unless they were validated, only indicator cell culture and bacteriological culture are considered as compendial methods for quality control of biological products. Nano-flow cytometry has been pointed out as an alternative technique for addressing prokaryotic and eukaryotic cell viability being a substantial tool for reference material production. In this study, a viability-flow-cytometry assay was standardized for M. gallisepticum and then applied to other cell-culture-contaminant mycoplasmas. For this, M. galliseticum’s growth rate was observed and different treatments were evaluated to establish low viability cultures (cell death-induced control). Distinct viability markers and their ideal concentrations (titration) were appraised. Ethanol treatment showed to be the best death-inducing control. CFDA and TOPRO markers revealed to be the best choice for detecting live and dead mycoplasma frequencies, respectively. The standardized methodology was applied to Mycoplasma arginini, M. hyorhinis, M. orale, Spiroplasma citri and Acholeplasma laidlawii. Significant statistical difference was observed in the percentage of viable cells in comparison to ethanol treatment for A. laidlawii in CFDA and in both markers for M. gallisepticum, M. hyorhinis and S. citri. In summary, we standardized a flow cytometry assay for assessing M. gallisepticum − and potentially other species – viability and ultimately applied for reference material production improving the quality control of biological products.
Similar content being viewed by others
References
Razin S, Hayflick L (2010) Highlights of mycoplasma research - an historical perspective. Biologicals 38:183–190
Koonin EV (2000) How many genes can make a cell: the minimal-gene-set concept . Annu. Rev Genomics Hum Genet 1(99):116
Rottem S, Barile MF (1993) Beware of mycoplasmas. Trends Biotechnol 11(4):143–151
Drexler HG, Uphoff CC (2002) Mycoplasma contamination of cell cultures: Incidence, sources, effects, detection, elimination, prevention. Cytotechnology 39:75–90
Olarerin-George AO, Hogenesch JB (2015) Assessing the prevalence of mycoplasma contamination in cell culture via a survey of NCBI’s RNA-seq archive. Nucleic Acids Res 43(5):2535–2542
Nikfarjam L, Farzaneh P (2012) Prevention and detection of mycoplasma contamination in cell culture. Cell J 13(4):203–212
European Pharmacopoeia. Mycoplasmas (2014) In: EUROPEAN pharmacopoeia, 8th ed.Council of Europe, Strasbourg.. Supplement 8.0. Chap. 2.6.7. pp 178–183.
The United States pharmacopeia. Mycoplasma tests. In: The United States pharmacopeia, 39th ed. The United States Pharmacopeial Convention, Rockville, 2016. v. 1. Chap. 1223. pp 130–136.
Volokhov DV, Graham LJ, Brorson KA, Chizhikov VE (2011) Mycoplasma testing of cell substrates and biologics: review of alternative non-microbiological techniques. Mol Cell Probes 25:69–77
Salling HK, Bang-Christensen SR (2016) Multi-primer qPCR assay capable of highly efficient and specific detection of the vast majority of all known Mycoplasma. Biologicals 44:129–138
Milne C, Daas A (2006) Establishment of European pharmacopoeia mycoplasma reference strains. Pharmeuropa Bio 1:57–72
Dabrazhynetskaya A, Volokhov DV, David SW, Ikonomi P, Brewer A, Chang A, Chizhikov V (2011) Preparation of reference strains for validation and comparison of mycoplasma testing methods. J Appl Microbiol 111:904–914
Nübling CM, Baylis SA, Hanschmann KM, Montag-Lessing T, Chudy M, Kreß J, Ulrych U, Czurda S, Rosengarten R; Mycoplasma Collaborative Study Group (2015)World Health Organization international standard To harmonize assays for detection of mycoplasma DNA. Appl Environ Microbiol 81(17):5694–5702
Wlodkowic D, Skommer J, Darzynkiewicz Z (2010) Cytometry in cell necrobiology revisited. Recent advances and new vistas. Cytometry Part A 77(7):591–606
JB Emerson, Adams RI, Román CMB, Brooks B, Coil DA, Dahlhausen K, Ganz HH, Hartmann EM, Hsu T, Justice NB, Paulino-Lima IG, Luongo JC, Lymperopoulou DS, Gomez-Silvan C, Rothschild-Mancinelli B, Balk M, Huttenhower C, Nocker A, Vaishampayan P, Rothschild LJ, (2017) Schrödinger’s microbes: tools for distinguishing the living from the dead in microbial ecosystems. Microbiome 5(1):86–99
Matsuoka H, Nakano K, Takatani N, Yoshida T, Igimi S, Saito M (2014) Flow cytometric method for in situ preparation of standard materials of a small defined number of microbial cells with colony-forming potentiality. J AOAC Int 97(2):479–483
Raymond Y, Champagne CP (2014) The use of flow cytometry to accurately ascertain total and viable counts of Lactobacillus rhamnosusin chocolate. Food Microbiol 46:176–183
Nolan JP, Jones JC (2017) Detection of platelet vesicles by flowcytometry. Platelets 28(3):256–262
Brittain GC, Chen YQ, Martinez E, Tang VA, Renner TM, Langlois MA, Gulnik S (2019) A novel semiconductor-based flow cytometer with enhanced lightscatter sensitivity for the analysis of biological nanoparticles. Nat Sci Rep 9(1):16039–21652
Nascimento ER (2000) Micoplasmoses. In: Berchieri Junior A, Macari M (eds) Doenças das aves, 1st edn. Facta, Campinas, pp 281–304
Arraud N, Gounou C, Turpin D, Brisson AR (2016) Fluorescence triggering: A general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry. Cytometry Part A 89(2):184–195
Wisgrill L, Lamm C, Hartmann J, Preißing F, Dragosits K, Bee A, Hell L, Thaler J, Ay C, Pabinger I, Berger A, Spittler A (2016) Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants. Cytometry Part A 89(7):663–672
May JD, Branton SL, Cuchens MA (1988) Identification of mycoplasma gallisepticum and M. synoviae by flow cytometry. Avian Dis 32(3):513–516
Assunção P, Rosales RS, Antunes NT, de la Fe C, Poveda JB (2007) Applications of flow cytometry to mycoplasmology. Frontiers in Bioscience 1(12):664–672
Milanovich N, Suh M, Jankowiak R, Small GJ, Hayes JM (1996) Binding of TO-PRO-3 and TOTO-3 to DNA: fluorescence and hole-burning studies. J Phys Chem A 100:9181–9186
Cavarec L, Quillet-Mary A, Fradelizi D, Conjeaud H (1990) An improved double fluorescence flow cytometry method for the quantification of killer cell/target cell conjugate formation. J Immunol Methods 130(2):251–261
Kaprelyants AS, Kell DB (1993) The use of 5-cyano-2,3-ditolyl tetrazolium chloride and flow cytometry for the visualisation of respiratory activity in individual cells of Micrococcus luteus. J Microbiol Methods 17:115–122
Serebryakova MV, Demina IA, Galyamina MA, Kondratov IG, Ladygina VG, Govorun VM (2011) The acylation state of surface lipoproteins of mollicute Acholeplasma laidlawii. J Biol Chem 286(26):22769–22776
Vanyushkina AA, Fisunov GY, Gorbachev AY, Kamashev DE, Govorun VM (2014) Metabolomic analysis of three mollicute species. PLoS ONE. https://doi.org/10.1371/journal.pone.0089312
Gandhi A, Shah NP (2015) Effect of salt on cell viability and membrane integrity of Lactobacillus acidophilus, Lactobacillus casei and Bifidobacterium longum as observed by flow cytometry. Food Microbiol 49:197–202. https://doi.org/10.1016/j.fm.2015.02.003
Kolek J, Branska B, Drahokoupil M, Patakova P, Melzoch K (2016) Evaluation of viability, metabolic activity and spore quantity in clostridial cultures during ABE fermentation. FEMS Microbiol Lett 363(6):1–8
Mohammadpour HA, Tracy CR, Redelman D, duPre’ SA (2010) Hunter KW (2010) Flow cytometric method for quantifying viable Mycoplasma agassizii, an agent of upper respiratory tract disease in the desert tortoise (Gopherus agassizii). Lett Appl Microbiol 50(4):347–351
Kerstens M, Boulet G, Tritsmans C, Horemans T, Hellings M, Delputte P, Maes L, Cos P (2014) Flow cytometric enumeration of bacteria using TO-PRO®-3 iodide as a single-stain viability dye. J Lab Automa 19(6):555–561
Ou F, McGoverin C, Swift S, Vanholsbeeck F (2017) Absolute bacterial cell enumeration using flow cytometry. J Appl Microbiol 123(5):464–477
Acknowledgments
This research was supported in part by an internal funding from IOC-FIOCRUZ-PAEF II–IOC-023-18-2-47 and FAPERJ E-26/010.002832/2014. The authors would like to thank to Immunoparasitology Lab., Oswaldo Cruz Institute, FIOCRUZ for the use of CytoFlex Flow Cytometer.
Author information
Authors and Affiliations
Contributions
RLF, MAS and ALB designed and conceived the study; RLF, MAS, TQC, VAC, SAS and ALB, performed acquisition, analysis and interpretation of data; RLF, MAS, TQC, ALB and IF wrote and extensively revised the manuscript. All authors have read and critically revised the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research Involving Human and Animal Participants
This article does not contain any studies with human or animal subjects.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lawson-Ferreira, R., Santiago, M.A., Chometon, T.Q. et al. Flow-Cytometric Method for Viability Analysis of Mycoplasma gallisepticum and Other Cell-Culture-Contaminant Mollicutes. Curr Microbiol 78, 67–77 (2021). https://doi.org/10.1007/s00284-020-02255-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-020-02255-1